These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3171331)

  • 1. Topical prostaglandin E2 effects on normal human intraocular pressure.
    Flach AJ; Eliason JA
    J Ocul Pharmacol; 1988; 4(1):13-8. PubMed ID: 3171331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of topical adrenergic agents on prostaglandin E2-induced aqueous flare and intraocular pressure elevation in pigmented rabbits.
    Nakamura-Shibasaki M; Latief MA; Ko JA; Funaishi K; Kiuchi Y
    Jpn J Ophthalmol; 2016 Mar; 60(2):95-102. PubMed ID: 26832333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys.
    Wang RF; Lee PY; Mittag TW; Podos SM; Serle JB; Becker B
    Arch Ophthalmol; 1998 Sep; 116(9):1213-6. PubMed ID: 9747682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety and ocular hypotensive effect of a new prostaglandin analogue, S-1033, in normal volunteers].
    Ando Y; Matsunami C; Yamamoto T; Kitazawa Y
    Nippon Ganka Gakkai Zasshi; 1994 Nov; 98(11):1109-14. PubMed ID: 7825505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aqueous prostaglandin E2 and intraocular pressure after argon laser trabeculoplasty in glaucoma patients pretreated with topical piroxicam.
    Dorigo MT; Doro D; Cecchinato A
    Int J Tissue React; 1987; 9(1):73-5. PubMed ID: 3474217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral haloperidol lowers human intraocular pressure.
    Sheppard JD; Schaid DJ
    J Ocul Pharmacol; 1986; 2(3):215-24. PubMed ID: 3503108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients.
    Camras CB; Siebold EC; Lustgarten JS; Serle JB; Frisch SC; Podos SM; Bito LZ
    Ophthalmology; 1989 Sep; 96(9):1329-36; discussion 1336-7. PubMed ID: 2780003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma.
    Rulo AH; Greve EL; Geijssen HC; Hoyng PF
    Ophthalmology; 1996 Aug; 103(8):1276-82. PubMed ID: 8764799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of d-timolol on intraocular pressure in patients with ocular hypertension.
    Keates EU; Stone R
    Am J Ophthalmol; 1984 Jul; 98(1):73-8. PubMed ID: 6742081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of topically applied prostaglandin F2 alpha tromethamine salt on glaucomatous human eyes.
    Erkiliç K; Ekinciler OF; Mirza GE; Doğan H; Cagil N
    Int J Clin Pharmacol Res; 1996; 16(2-3):51-5. PubMed ID: 9063756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prostaglandin D2 and its analogues on intraocular pressure in rabbits.
    Goh Y; Nakajima M; Azuma I; Hayaishi O
    Jpn J Ophthalmol; 1988; 32(4):471-80. PubMed ID: 3236567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel dopamine D-1 antagonist and D-2 agonist, SDZ GLC-756, lowers intraocular pressure in healthy human volunteers and in patients with glaucoma.
    Prünte C; Flammer J
    Ophthalmology; 1995 Sep; 102(9):1291-7. PubMed ID: 9097765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ocular effects of topical instillation of UF-021 ophthalmic solution in healthy volunteers].
    Takase M; Murao M; Koyano S; Okita M; Ueno R
    Nippon Ganka Gakkai Zasshi; 1992 Oct; 96(10):1261-7. PubMed ID: 1442350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers.
    Tanihara H; Inatani M; Honjo M; Tokushige H; Azuma J; Araie M
    Arch Ophthalmol; 2008 Mar; 126(3):309-15. PubMed ID: 18332309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1 clinical trials of a selective Rho kinase inhibitor, K-115.
    Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Araie M;
    JAMA Ophthalmol; 2013 Oct; 131(10):1288-95. PubMed ID: 23787820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular hypotensive effects of cholinergic and adrenergic drugs may be influenced by prostaglandins E2 in the human and rabbit eye.
    Kaplan-Messas A; Naveh N; Avni I; Marshall J
    Eur J Ophthalmol; 2003; 13(1):18-23. PubMed ID: 12635670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acepromazine. Effects on intraocular pressure.
    Hayreh SS; Kardon RH; McAllister DL; Fleury PJ
    Arch Ophthalmol; 1991 Jan; 109(1):119-24. PubMed ID: 1987928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost.
    Costagliola C; Campa C; Perri P; Parmeggiani F; Romano MR; Incorvaia C
    Curr Eye Res; 2008 May; 33(5):477-82. PubMed ID: 18568885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.